Herein, we review four investigational methods for enhancing tumor-targeted delivery of PD-1/PD-L1 ICIs, namely, locoregional, oncolytic virus-, nanoparticle-, and ultrasound and microbubble-mediated administration techniques (summarized in Table 1). Here, CD274 is linked to neoplasm.